Iranian Journal of Pediatrics

Published by: Kowsar

Efficacy of Post-Exposure Prophylaxis in Infants Born to HBsAg Positive Mothers in Iran; Is It Authentic?

Zahra Ahmadinejad 1 , * , Zahra Abdi Liae 1 , Saideh Salehizadeh 2 , Sedighe Mansori 1 and Neda Alijani 3
Authors Information
1 Department of Infectious Diseases, Imam Khomeini Complex Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
2 Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Infectious Diseases, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Journal of Pediatrics: June 2016, 26 (3); e5979
  • Published Online: May 21, 2016
  • Article Type: Research Article
  • Received: March 11, 2016
  • Revised: April 22, 2016
  • Accepted: May 8, 2016
  • DOI: 10.5812/ijp.5979

To Cite: Ahmadinejad Z, Abdi Liae Z, Salehizadeh S, Mansori S, Alijani N. et al. Efficacy of Post-Exposure Prophylaxis in Infants Born to HBsAg Positive Mothers in Iran; Is It Authentic?, Iran J Pediatr. 2016 ; 26(3):e5979. doi: 10.5812/ijp.5979.

Abstract
Copyright © 2016, Growth & Development Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Screening for chronic hepatitis B among Asian/Pacific Islander populations--New York City, 2005. MMWR Morb Mortal Wkly Rep. 2006; 55(18): 505-9[PubMed]
  • 2. Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut. 1996; 38 Suppl 2-23[PubMed]
  • 3. Hepatitis B fact sheet N 204 . 2014;
  • 4. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol. 1979; 3(3): 237-41[PubMed]
  • 5. Edlich RF, Diallo AO, Buchanan L, Martin ML. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States. J Long Term Eff Med Implants. 2003; 13(2): 117-25[PubMed]
  • 6. Beasley RP, Hwang LY, Stevens CE, Lin CC, Hsieh FJ, Wang KY, et al. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology. 1983; 3(2): 135-41[PubMed]
  • 7. Patton H, Tran TT. Management of hepatitis B during pregnancy. Nat Rev Gastroenterol Hepatol. 2014; 11(7): 402-9[DOI][PubMed]
  • 8. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975; 292(15): 771-4[DOI][PubMed]
  • 9. Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci. 1993; 253(1337): 197-201[DOI][PubMed]
  • 10. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst. 2009; 101(19): 1348-55[DOI][PubMed]
  • 11. Wong VC, Ip HM, Reesink HW, Lelie PN, Reerink-Brongers EE, Yeung CY, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet. 1984; 1(8383): 921-6[PubMed]
  • 12. Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983; 2(8359): 1099-102[PubMed]
  • 13. Lin HH, Chang MH, Chen DS, Sung JL, Hong KH, Young YC, et al. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine. 1991; 9(6): 457-60[PubMed]
  • 14. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis. 1998; 27(1): 100-6[PubMed]
  • 15. Lee SD, Lo KJ, Tsai YT, Wu JC, Wu TC, Yang ZL, et al. Role of caesarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet. 1988; 2(8615): 833-4[PubMed]
  • 16. Wang J, Zhu Q, Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J (Engl). 2002; 115(10): 1510-2[PubMed]
  • 17. Mulligan MJ, Stiehm ER. Neonatal hepatitis B infection: clinical and immunologic considerations. J Perinatol. 1994; 14(1): 2-9[PubMed]
  • 18. Fiore AE. Chronic maternal hepatitis B infection and premature rupture of membranes. Pediatr Infect Dis J. 2002; 21(4): 357-8[PubMed]
  • 19. Lin HH, Kao JH, Hsu HY, Mizokami M, Hirano K, Chen DS. Least microtransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol. 1996; 87(2): 244-8[DOI][PubMed]
  • 20. Salisbury D, Noakes K. Immunisation against infectious diseases (The Green Book). 2009; : 161-84
  • 21. Boxall E, Skidmore S, Evans C, Nightingale S. The prevalence of hepatitis B and C in an antenatal population of various ethnic origins. Epidemiol Infect. 1994; 113(3): 523-8[PubMed]
  • 22. Batham A, Narula D, Toteja T, Sreenivas V, Puliyel JM. Sytematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatr. 2007; 44(9): 663-74[PubMed]
  • 23. Yahyapour Y, Karimi M, Molaei HR, Khoddami E, Mahmoudi M. Active-passive Immunization Effectiveness Against Hepatitis B Virus in Children Born to HBsAg Positive Mothers in Amol, North of Iran. Oman Med J. 2011; 26(6): 399-403[DOI][PubMed]
  • 24. Lazarus J. Global policy report on the prevention and control of viral hepatitis in WHO Member States. 2014;
  • 25. Hepatitis B vaccines: WHO position paper--recommendations. Vaccine. 2010; 28(3): 589-90[DOI][PubMed]
  • 26. Koyama T, Matsuda I, Sato S, Yoshizawa H. Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan (1981-1992) and epidemiological evidence for its efficacy. Hepatol Res. 2003; 26(4): 287-92[PubMed]
  • 27. Evans AA, Cohen C, Huang P, Qian L, London WT, Block JM, et al. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative. Vaccine. 2015; 33(26): 3010-5[DOI][PubMed]
  • 28. Hahne S, van den Hoek A, Baayen D, van der Sande M, de Melker H, Boot H. Prevention of perinatal hepatitis B virus transmission in the Netherlands, 2003-2007: children of Chinese mothers are at increased risk of breakthrough infection. Vaccine. 2012; 30(9): 1715-20[DOI][PubMed]
  • 29. Wu JS, Hwang LY, Goodman KJ, Beasley RP. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis. 1999; 179(6): 1319-25[DOI][PubMed]
  • 30. Mele A, Tancredi F, Romano L, Giuseppone A, Colucci M, Sangiuolo A, et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis. 2001; 184(7): 905-8[DOI][PubMed]
  • 31. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ. 2006; 332(7537): 328-36[DOI][PubMed]
  • 32. Song YM, Sung J, Yang S, Choe YH, Chang YS, Park WS. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr. 2007; 166(8): 813-8[DOI][PubMed]
  • 33. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Srinivasa K, Hutagalung Y, Bock HL, et al. Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers. J Infect Dis. 2009; 200(1): 33-8[DOI][PubMed]
  • 34. Alavian SM, Behnava B. What is the reason for poor outcome of antepartum immunoprophylaxis of Hepatitis B Immunoglobulin in prevention of vertical hepatitis B transmission. Hepat Mon. 2007; 7(3): 163-5
  • 35. Hassanjani-Roshan MR, Zahed-Pasha Y. Efficacy of HBIG and Vaccine in infants of HBsAg positive carrier mothers. Arch Irn Med. 2002; 5(1): 21-3
  • 36. Salman K, Priti S, Molly M, Kumar VS, Zeenat S. Hepatitis B virus infection in pregnant women and transmission to newborns. Asian Pac J Trop Dis. 2015; 5(6): 421-9[DOI]
  • 37. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1990; 39: 1-26[PubMed]
  • 38. Marcdante K. J. , Kliegman RM, Jenson HB, Behrman RE. Nelson Essentials of Pediatrics. 2010;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments